Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zbigniew Rudzki

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Ejhaem|January 31, 2023
Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell and plasma exchangeSyed Rizvi, Muhammad Khakwani, Shivan Pancham, et al.
Pathology Oncology Research : POR|February 11, 2019
Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell LymphomaGhada Mohamed, Soha Talima, Lili Li, et al.
Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
International Journal of Hematology|September 19, 2007
The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical studyZbigniew Rudzki, Tomasz Sacha, Anastazja Stój, et al.
Archivum Immunologiae Et Therapiae Experimentalis|December 2, 2008
Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndromeMaciej Siedlar, Zbigniew Rudzki, Magdalena Strach, et al.
Przeglad Lekarski|April 24, 2012
[Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up]Ewa Ignacak, Alina Betkowska-Prokop, Marek Kuźniewski, et al.
Pathology|July 21, 2005
The prevalence of inherited thrombophilias in a Caucasian Australian populationCatherine S Gibson, Alastair H MacLennan, Zbigniew Rudzki, et al.
Leukemia Research|August 19, 2003
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisisTomasz Sacha, Andreas Hochhaus, Benjamin Hanfstein, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|June 1, 2005
ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature reviewZbigniew Rudzki, Małgorzata Rucińska, Wojciech Jurczak, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Ejhaem|January 31, 2023
Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell and plasma exchangeSyed Rizvi, Muhammad Khakwani, Shivan Pancham, et al.
Pathology Oncology Research : POR|February 11, 2019
Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell LymphomaGhada Mohamed, Soha Talima, Lili Li, et al.
Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
International Journal of Hematology|September 19, 2007
The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical studyZbigniew Rudzki, Tomasz Sacha, Anastazja Stój, et al.
Archivum Immunologiae Et Therapiae Experimentalis|December 2, 2008
Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndromeMaciej Siedlar, Zbigniew Rudzki, Magdalena Strach, et al.
Przeglad Lekarski|April 24, 2012
[Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up]Ewa Ignacak, Alina Betkowska-Prokop, Marek Kuźniewski, et al.
Pathology|July 21, 2005
The prevalence of inherited thrombophilias in a Caucasian Australian populationCatherine S Gibson, Alastair H MacLennan, Zbigniew Rudzki, et al.
Leukemia Research|August 19, 2003
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisisTomasz Sacha, Andreas Hochhaus, Benjamin Hanfstein, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|June 1, 2005
ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature reviewZbigniew Rudzki, Małgorzata Rucińska, Wojciech Jurczak, et al.
Pageof 6